A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT00918203 · COMPLETED
Trial details
- NCT number
- NCT00918203
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2013-08-01
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.